about
Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritisModulation of IL-17 and Foxp3 expression in the prevention of autoimmune arthritis in miceGenetic Predictors of Poor Prognosis in Portuguese Patients with Juvenile Idiopathic Arthritis: Data from Reuma.pt.Rituximab use in pediatric autoimmune diseases: four case reports.Chronic arthritis leads to disturbances in the bone collagen network.A quantitative comparison of a bone remodeling model with dual-energy X-ray absorptiometry and analysis of the inter-individual biological variability of femoral neck T-score.Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing.Cross-sectional study of 50 patients with calcium pyrophosphate dihydrate crystal arthropathy.Rebalancing bone turnover in favour of formation with strontium ranelate: implications for bone strength.Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments.Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis.Early vascular alterations in SLE and RA patients--a step towards understanding the associated cardiovascular risk.Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?Osteoblasts and bone formation.Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile.Gender-specific effects of genetic variants within Th1 and Th17 cell-mediated immune response genes on the risk of developing rheumatoid arthritis.Patient's access to healthcare and treatment in rheumatoid arthritis: the views of stakeholders in Portugal.Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspectsInfluence of human leucocyte antigen-DRB1 on the susceptibility to rheumatoid arthritis and on the production of anti-cyclic citrullinated peptide antibodies in a Portuguese populationTreating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire.Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients.Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoterComparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis.Interleukin-6 as a key player in systemic inflammation and joint destruction.Biomechanical effects of inflammatory diseases on bone-rheumatoid arthritis as a paradigm.Potent anti-inflammatory and antiproliferative effects of gambogic acid in a rat model of antigen-induced arthritis.Neutrophils in rheumatoid arthritis: More than simple final effectors.Methotrexate treatment in rheumatoid arthritis: management in clinical remission, common infection and tuberculosis. Results from a systematic literature review.Rheumatoid arthritis: what is refractory disease and how to manage it?Primary biliary cirrhosis in a rheumatoid arthritis patient treated with rituximab, a case-based review.Bilateral MR imaging of the hand and wrist in early and very early inflammatory arthritis: tenosynovitis is associated with progression to rheumatoid arthritis.Pachydermoperiostosis in an African patient caused by a Chinese/Japanese SLCO2A1 mutation-case report and review of literature.Biosimilar DMARDs: What Does the Future Hold?Pharmacoeconomics of Biosimilars: What Is There to Gain from Them?Factors influencing calcaneus quantitative ultrasound measurements in an urban population.Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis.Polymorphism at position -308 of the tumour necrosis factor alpha gene and rheumatoid arthritis pharmacogenetics.Alterations on peripheral blood B-cell subpopulations in very early arthritis patients.ANKH and susceptibility to and severity of ankylosing spondylitis.Identification of La ribonucleoproteins as a component of interchromatin granules.
P50
Q28489093-02374499-B96C-4691-BFA5-94B4D0EA3D92Q30982756-EAB7FDE1-CF2B-4B8A-B2D7-9B66E1B03957Q31011687-F63095EF-086B-4887-927F-12D733313D82Q33386255-2917138F-FA74-4C70-89DE-4AB461765A77Q33524546-E4577966-3D1F-40EE-8ED0-4763CF580F3EQ33672519-7455340B-0522-4D11-95EA-A35FE01B2460Q33828462-A817CFBC-F9D1-458C-8146-A7080FD14344Q33946213-DF0AF50B-44BF-4123-947E-43E482D50070Q34012271-F151832A-4EE7-430C-A518-56A06F1FDF96Q34138502-EB28F1D4-3BC1-4593-B9C2-7B447A3EB505Q34346409-F3A0B1F4-A2AE-4DBF-98E9-EB301B93C01EQ34409903-73A53551-A615-40AB-BA4D-C1C72C168842Q34559803-A58D6B7A-719B-4BFC-9433-E9C240FA9A1DQ34638037-F7BB948B-92E1-426A-8031-39E9D47B962AQ34655140-4DE3D3F4-C145-4C85-B889-D2F78357E82EQ34983577-8EEC54B0-1C42-46FD-879F-9D10F6834E04Q34997800-69F86585-E884-4BEC-BF73-98F563C27ED1Q35092997-0BC64DB7-4A6E-4B80-93FC-01ABA32C5EB2Q35638730-FB742D6B-A71C-4259-8ACC-E239A846992EQ35740447-65D63474-2F69-4774-A070-CA69E4DF4E1CQ35840828-E9D3ADDD-E84B-4927-B546-43D413C5ABDCQ35869031-61D26B87-A248-4EA5-8832-BAF4003FD951Q36331865-8894EB2E-497A-4C2F-90AC-3A90B71222CAQ37384484-E11328C9-86E8-47C5-9899-7D5538D98D97Q37395112-5B868FA3-5624-4380-BB87-3AE8D7F61E2FQ37593444-293C2F56-8275-41B3-B001-8D87FF459A13Q37671155-EB3CEFE1-464B-454E-AF0C-9136E40BC67BQ37689022-445484BE-13B6-45A4-B65A-E5A1810A415CQ37875394-82F19879-E099-4103-A902-A4085FD31C35Q37951386-10AFAAA2-2266-49D4-AC3A-665E8BF08B3EQ38020815-963003FB-15D7-4FFD-9B19-BDE2F39DA632Q38135042-243BCE37-9CBF-4AF3-8CEC-5D2132D9AADDQ38760042-633030A1-B720-4336-B802-53889C3B5EC0Q38893192-5452D849-C595-4D86-A99D-C17FEA61B0B4Q39838123-3ADD6E7D-F769-49D2-86D4-4F07CEB4BF65Q41883420-7B0B1F97-7F4C-4164-8728-E7F67A460FC1Q43048825-C787E262-5B52-4A56-A107-326DF3880177Q43138273-65348B7C-F351-42F3-A209-996C9F60E896Q44084338-EFBE23DC-D053-47EE-8FD0-25E4A73B3019Q45201978-B157B526-8E29-47F3-99CF-E442EABFA40D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
João E. Fonseca
@ast
João E. Fonseca
@en
João E. Fonseca
@es
João E. Fonseca
@nl
João E. Fonseca
@sl
type
label
João E. Fonseca
@ast
João E. Fonseca
@en
João E. Fonseca
@es
João E. Fonseca
@nl
João E. Fonseca
@sl
prefLabel
João E. Fonseca
@ast
João E. Fonseca
@en
João E. Fonseca
@es
João E. Fonseca
@nl
João E. Fonseca
@sl
P106
P1153
7101983519
P21
P31
P496
0000-0003-1432-3671